Multiple Therapies in Treating Patients With Advanced Neuroblastoma
Public ClinicalTrials.gov record NCT00040872. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
N8: Dose-Intensive Chemotherapy Plus Biologics in the Treatment of Neuroblastoma
Study identification
- NCT ID
- NCT00040872
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- filgrastim Biological
- monoclonal antibody 3F8 Biological
- sargramostim Biological
- carboplatin Drug
- cisplatin Drug
- cyclophosphamide Drug
- doxorubicin hydrochloride Drug
- etoposide Drug
- isotretinoin Drug
- thiotepa Drug
- topotecan hydrochloride Drug
- vincristine sulfate Drug
- autologous bone marrow transplantation Procedure
- bone marrow ablation with stem cell support Procedure
- conventional surgery Procedure
- drug resistance inhibition treatment Procedure
- peripheral blood stem cell transplantation Procedure
- syngeneic bone marrow transplantation Procedure
- radiation therapy Radiation
Biological · Drug · Procedure + 1 more
Eligibility (public fields only)
- Age range
- Up to 50 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2000
- Primary completion
- Dec 31, 2006
- Completion
- Dec 31, 2006
- Last update posted
- Mar 6, 2013
2000 – 2007
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10021 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00040872, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 6, 2013 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00040872 live on ClinicalTrials.gov.